|
시장보고서
상품코드
2152204
의료 커뮤니케이션 시장 규모, 점유율 및 동향 분석 보고서 : 서비스별, 제공 형태별, 최종 용도별, 지역별 및 부문별 전망(2026-2033년)Medical Communication Market Size, Share & Trends Analysis Report By Service (Scientific And Publication Communications, Medical Affairs Communications), By Delivery Mode (Digital, In-person), By End Use, By Region, And Segment Forecasts, 2026 - 2033 |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
의료 커뮤니케이션 시장 요약
세계 의료 커뮤니케이션 시장 규모는 2025년에 28억 달러로 평가되었고, 2026년 31억 달러에서 2033년까지 61억 달러로 성장할 것으로 예상되며, 2026-2033년 연평균 성장률(CAGR)은 10.3%를 나타낼 것으로 전망됩니다.
북미가 시장을 주도하고 있으며, 2025년 매출 점유율은 44.6%를 차지했습니다. 과학·임상 정보, 근거 기반 커뮤니케이션 및 전문적인 메디컬 라이팅에 대한 수요가 증가함에 따라 이 업계는 확대되고 있습니다.
제약 회사와 생명공학 기업들은 간행물, 교육 자료, 그리고 이해관계자와의 소통에 있어 의료 커뮤니케이션 제공업체에 대한 의존도를 높이고 있습니다. 인공지능과 디지털 플랫폼의 활용으로 컨텐츠 개발, 문헌 분석, 개인화, 그리고 커뮤니케이션의 효율성이 향상되고 있습니다.
또한, 임상 데이터의 복잡성이 증가하고 있으며, 정확하고 다중 채널을 통한 과학적 커뮤니케이션에 대한 수요가 높아짐에 따라, 예측 기간 동안 시장의 성장이 지속될 것으로 전망됩니다.
자주 묻는 질문
목차
제1장 조사 방법 및 범위
제2장 요약
제3장 세계 의료 커뮤니케이션 시장 : 변수, 동향, 범위
- 시장 전망
- 시장 역학
- 세계 의료 커뮤니케이션: 시장 분석 도구
- 사례 연구
제4장 세계 의료 커뮤니케이션 시장 : 서비스별 부문 분석, 2021년-2033년
- 서비스별 시장 점유율 분석, 2025년-2033년
- 세계 의료 커뮤니케이션 시장 : 서비스별, 2021년-2033년
- 과학·출판 커뮤니케이션
- 메디컬 어페어스 커뮤니케이션
- 의료 교육
- 이벤트 커뮤니케이션
- 홍보 목적의 메디컬 커뮤니케이션
- 환자 대상 커뮤니케이션
- 기타
제5장 세계 의료 커뮤니케이션 시장 부문 분석 : 전달 방식별, 2021년-2033년
- 전달 방식별 시장 점유율 분석, 2025년-2033년
- 세계 의료 커뮤니케이션 시장 : 전달 방식별, 2021년-2033년
- 디지털
- 대면
- 기타
제6장 세계 의료 커뮤니케이션 시장 부문 분석 : 최종 용도별, 2021년-2033년
- 최종 용도별 시장 점유율 분석, 2025년-2033년
- 세계 의료 커뮤니케이션 시장 : 최종 용도별, 2021년-2033년
- 제약 회사
- 생명공학 기업
- 의료기기 제조업체
- 의료 서비스 제공업체
- 보험사/의료보험 제공업체
- 정부 기관
- 기타
제7장 의료 커뮤니케이션 시장 부문 분석 : 지역별, 2021년-2033년
- 지역별 시장 점유율 분석, 2025년-2033년
- 지역별 시장 대시보드
- 지역별 시장 개요
- 의료 커뮤니케이션 시장 점유율: 지역별, 2025년-2033년
- 북미
- 미국
- 캐나다
- 멕시코
- 유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 노르웨이
- 스웨덴
- 덴마크
- 아시아태평양
- 일본
- 중국
- 인도
- 호주
- 한국
- 태국
- 라틴아메리카
- 브라질
- 아르헨티나
- 중동 및 아프리카
- 남아프리카
- 사우디아라비아
- 아랍에미리트(UAE)
- 쿠웨이트
제8장 경쟁 현황
- 주요 시장 진출 기업별 최근 동향 및 영향 분석
- 기업 분류
- Commercial Strategies
- 기업 프로파일
- Inizio.
- Indegene
- Costello Medical Consulting Limited
- Syneos Health.
- OPEN Health
- Real Chemistry
- Health Inc.
- VML.
- Amiculum.
- Cactus Life Sciences.
- Avalere Health Group.
- Oxford PharmaGenesis（Klick Inc.）
Medical Communication Market Summary
The global medical communication market size was valued at USD 2.8 billion in 2025 and is projected to grow from USD 3.1 billion in 2026 to USD 6.1 billion by 2033, at a CAGR of 10.3% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 44.6% in 2025. The industry is expanding due to growing demand for scientific and clinical information, evidence-based communication, and specialized medical writing.
Pharmaceutical and biotechnology companies are relying more on medical communication providers for publications, educational materials, and stakeholder communications. The use of artificial intelligence and digital platforms is enhancing content development, literature analysis, personalization, and communication efficiency.
In addition, the increasing complexity of clinical data and the need for accurate, multi-channel scientific communication are expected to drive ongoing market growth during the forecast period.
Global Medical Communication Market Report Segmentation
This report forecasts revenue growth at the global, regional, & country levels and provides an analysis of the latest industry trends and opportunities in each sub segment from 2021 to 2033. For this study, Grand View Research has segmented the global medical communication market report based on service, delivery mode, end use, and region:
- Service Outlook (Revenue, USD Billion, 2021 - 2033)
- Scientific and publication communications
- Medical affairs communications
- Medical education
- Event communications
- Promotional medical communications
- Patient communications
- Others
- Delivery Mode Outlook (Revenue, USD Billion, 2021 - 2033)
- Digital
- In-person
- Others
- End Use Outlook (Revenue, USD Billion, 2021 - 2033)
- Pharmaceutical companies
- Biotechnology firms
- Medical device manufacturers
- Healthcare providers
- Insurance companies/Healthcare payers
- Government agencies
- Others
- Regional Outlook (Revenue, USD Billion, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- Australia
- India
- South Korea
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Segment scope
- 1.1.2. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. Research Assumptions
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Service type outlook
- 2.2.2. Delivery mode
- 2.2.3. End use outlook
- 2.3. Competitive Insights
Chapter 3. Global Medical Communication Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.2. Market restraint analysis
- 3.2.3. Market opportunity analysis
- 3.2.4. Market challenges analysis
- 3.3. Global Medical Communication: Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's five forces analysis
- 3.3.2. PESTLE Analysis
- 3.4. Case study
Chapter 4. Global Medical Communication Market Segment Analysis, By Service, 2021 - 2033 (Revenue in USD Billion)
- 4.1. Definition and Scope
- 4.2. Service Market Share Analysis, 2025 & 2033
- 4.3. Segment Dashboard
- 4.4. Global Medical Communication Market, by Service, 2021 to 2033
- 4.4.1. Scientific and Publication Communications
- 4.4.1.1. Scientific and publication communications market estimates and forecasts 2021 To 2033 (USD Billion)
- 4.4.2. Medical Affairs Communications
- 4.4.2.1. Medical affairs communications market estimates and forecasts 2021 To 2033 (USD Billion)
- 4.4.3. Medical Education
- 4.4.3.1. Medical education market estimates and forecasts 2021 To 2033 (USD Billion)
- 4.4.4. Event Communications
- 4.4.4.1. Event communications market estimates and forecasts 2021 To 2033 (USD Billion)
- 4.4.5. Promotional Medical Communications
- 4.4.5.1. Promotional Medical communications market estimates and forecasts 2021 To 2033 (USD Billion)
- 4.4.6. Patient Communications
- 4.4.6.1. Patient communications market estimates and forecasts 2021 To 2033 (USD Billion)
- 4.4.7. Others
- 4.4.7.1. Others market estimates and forecasts 2021 To 2033 (USD Billion)
- 4.4.1. Scientific and Publication Communications
Chapter 5. Global Medical Communication Market Segment Analysis, By Delivery Mode, 2021 - 2033 (USD Billion)
- 5.1. Definition and Scope
- 5.2. Delivery Mode Market Share Analysis, 2025 & 2033
- 5.3. Segment Dashboard
- 5.4. Global Medical Communication Market, by Delivery Mode, 2021 to 2033
- 5.5. Digital
- 5.5.1. Digital market estimates and forecasts 2021 To 2033 (USD Billion)
- 5.6. In-person
- 5.6.1. In-person market estimates and forecasts 2021 To 2033 (USD Billion)
- 5.7. Others
- 5.7.1. Others market estimates and forecasts 2021 To 2033 (USD Billion)
Chapter 6. Global Medical Communication Market Segment Analysis, By End Use, 2021 - 2033 (USD Billion)
- 6.1. Definition and Scope
- 6.2. End use Market Share Analysis, 2025 & 2033
- 6.3. Segment Dashboard
- 6.4. Global Medical Communication Market, by End Use, 2021 to 2033
- 6.5. Pharmaceutical Companies
- 6.5.1. Pharmaceutical companies market estimates and forecasts, 2021 to 2033 (USD Billion)
- 6.6. Biotechnology Firms
- 6.6.1. Biotechnology firms market estimates and forecasts, 2021 to 2033 (USD Billion)
- 6.7. Medical Device Manufacturers
- 6.7.1. Medical device manufactures market estimates and forecasts, 2021 to 2033 (USD Billion)
- 6.8. Healthcare Providers
- 6.8.1. Healthcare providers market estimates and forecasts, 2021 to 2033 (USD Billion)
- 6.9. Insurance Companies/ Healthcare Payers
- 6.9.1. Insurance companies/Healthcare payers market estimates and forecasts, 2021 to 2033 (USD Billion)
- 6.10. Government Agencies
- 6.10.1. Government agencies market estimates and forecasts, 2021 to 2033 (USD Billion)
- 6.11. Others
- 6.11.1. Others market estimates and forecasts, 2021 to 2033 (USD Billion)
Chapter 7. Medical Communication Market Segment Analysis, By Region, 2021 - 2033 (USD Billion)
- 7.1. Regional Market Share Analysis, 2025 & 2033
- 7.2. Regional Market Dashboard
- 7.3. Regional Market Snapshot
- 7.4. Medical Communication Market Share by Region, 2025 & 2033:
- 7.5. North America
- 7.5.1. North America Medical Communication market, 2021 - 2033 (USD Billion)
- 7.5.2. U.S.
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Regulatory Scenario
- 7.5.2.3. Competitive Scenario
- 7.5.2.4. U.S. Medical Communication Market, 2021 To 2033 (USD Billion)
- 7.5.3. Canada
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Regulatory Scenario
- 7.5.3.3. Competitive Scenario
- 7.5.3.4. Canada Medical Communication Market, 2021 To 2033 (USD Billion)
- 7.5.4. Mexico
- 7.5.4.1. Key Country Dynamics
- 7.5.4.2. Regulatory Scenario
- 7.5.4.3. Competitive Scenario
- 7.5.4.4. Mexico Medical Communication Market, 2021 To 2033 (USD Billion)
- 7.6. Europe
- 7.6.1. Europe Medical Communication market, 2021 - 2033 (USD Billion)
- 7.6.2. UK
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Regulatory Scenario
- 7.6.2.3. Competitive Scenario
- 7.6.2.4. UK Medical Communication Market, 2021 To 2033 (USD Billion)
- 7.6.3. Germany
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Regulatory Scenario
- 7.6.3.3. Competitive Scenario
- 7.6.3.4. Germany Medical Communication Market, 2021 To 2033 (USD Billion)
- 7.6.4. France
- 7.6.4.1. Key Country Dynamics
- 7.6.4.2. Regulatory Scenario
- 7.6.4.3. Competitive Scenario
- 7.6.4.4. France Medical Communication Market, 2021 To 2033 (USD Billion)
- 7.6.5. Italy
- 7.6.5.1. Key Country Dynamics
- 7.6.5.2. Regulatory Scenario
- 7.6.5.3. Competitive Scenario
- 7.6.5.4. Italy Medical Communication Market, 2021 To 2033 (USD Billion)
- 7.6.6. Spain
- 7.6.6.1. Key Country Dynamics
- 7.6.6.2. Regulatory Scenario
- 7.6.6.3. Competitive Scenario
- 7.6.6.4. Spain Medical Communication Market, 2021 To 2033 (USD Billion)
- 7.6.7. Norway
- 7.6.7.1. Key Country Dynamics
- 7.6.7.2. Regulatory Scenario
- 7.6.7.3. Competitive Scenario
- 7.6.7.4. Norway Medical Communication Market, 2021 To 2033 (USD Billion)
- 7.6.8. Sweden
- 7.6.8.1. Key Country Dynamics
- 7.6.8.2. Regulatory Scenario
- 7.6.8.3. Competitive Scenario
- 7.6.8.4. Sweden Medical Communication Market, 2021 To 2033 (USD Billion)
- 7.6.9. Denmark
- 7.6.9.1. Key Country Dynamics
- 7.6.9.2. Regulatory Scenario
- 7.6.9.3. Competitive Scenario
- 7.6.9.4. Denmark Medical Communication Market, 2021 To 2033 (USD Billion)
- 7.7. Asia Pacific
- 7.7.1. Japan
- 7.7.1.1. Key Country Dynamics
- 7.7.1.2. Regulatory Scenario
- 7.7.1.3. Competitive Scenario
- 7.7.1.4. Japan Medical Communication Market, 2021 To 2033 (USD Billion)
- 7.7.2. China
- 7.7.2.1. Key Country Dynamics
- 7.7.2.2. Regulatory Scenario
- 7.7.2.3. Competitive Scenario
- 7.7.2.4. China Medical Communication Market, 2021 To 2033 (USD Billion)
- 7.7.3. India
- 7.7.3.1. Key Country Dynamics
- 7.7.3.2. Regulatory Scenario
- 7.7.3.3. Competitive Scenario
- 7.7.3.4. India Medical Communication Market, 2021 To 2033 (USD Billion)
- 7.7.4. Australia
- 7.7.4.1. Key Country Dynamics
- 7.7.4.2. Regulatory Scenario
- 7.7.4.3. Competitive Scenario
- 7.7.4.4. Australia Medical Communication Market, 2021 To 2033 (USD Billion)
- 7.7.5. South Korea
- 7.7.5.1. Key Country Dynamics
- 7.7.5.2. Regulatory Scenario
- 7.7.5.3. Competitive Scenario
- 7.7.5.4. South Korea Medical Communication Market, 2021 To 2033 (USD Billion)
- 7.7.6. Thailand
- 7.7.6.1. Key Country Dynamics
- 7.7.6.2. Regulatory Scenario
- 7.7.6.3. Competitive Scenario
- 7.7.6.4. Thailand Medical Communication Market, 2021 To 2033 (USD Billion)
- 7.7.1. Japan
- 7.8. Latin America
- 7.8.1. Brazil
- 7.8.1.1. Key Country Dynamics
- 7.8.1.2. Regulatory Scenario
- 7.8.1.3. Competitive Scenario
- 7.8.1.4. Brazil Medical Communication Market, 2021 To 2033 (USD Billion)
- 7.8.2. Argentina
- 7.8.2.1. Key Country Dynamics
- 7.8.2.2. Regulatory Scenario
- 7.8.2.3. Competitive Scenario
- 7.8.2.4. Argentina Medical Communication Market, 2021 To 2033 (USD Billion)
- 7.8.1. Brazil
- 7.9. MEA
- 7.9.1. South Africa
- 7.9.1.1. Key Country Dynamics
- 7.9.1.2. Regulatory Scenario
- 7.9.1.3. Competitive Scenario
- 7.9.1.4. South Africa Medical Communication Market, 2021 To 2033 (USD Billion)
- 7.9.2. Saudi Arabia
- 7.9.2.1. Key Country Dynamics
- 7.9.2.2. Regulatory Scenario
- 7.9.2.3. Competitive Scenario
- 7.9.2.4. Saudi Arabia Medical Communication Market, 2021 To 2033 (USD Billion)
- 7.9.3. UAE
- 7.9.3.1. Key Country Dynamics
- 7.9.3.2. Regulatory Scenario
- 7.9.3.3. Competitive Scenario
- 7.9.3.4. UAE Medical Communication Market, 2021 To 2033 (USD Billion)
- 7.9.4. Kuwait
- 7.9.4.1. Key Country Dynamics
- 7.9.4.2. Regulatory Scenario
- 7.9.4.3. Competitive Scenario
- 7.9.4.4. Kuwait Medical Communication Market, 2021 To 2033 (USD Billion)
- 7.9.1. South Africa
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company Categorization
- 8.3. Commercial Strategies
- 8.4. Company Profiles
- 8.4.1. Inizio.
- 8.4.1.1. Company overview
- 8.4.1.2. Financial performance
- 8.4.1.3. Product benchmarking
- 8.4.1.4. Strategic initiatives
- 8.4.2. Indegene
- 8.4.2.1. Company overview
- 8.4.2.2. Financial performance
- 8.4.2.3. Product benchmarking
- 8.4.2.4. Strategic initiatives
- 8.4.3. Costello Medical Consulting Limited
- 8.4.3.1. Company overview
- 8.4.3.2. Financial performance
- 8.4.3.3. Product benchmarking
- 8.4.3.4. Strategic initiatives
- 8.4.4. Syneos Health.
- 8.4.4.1. Company overview
- 8.4.4.2. Financial performance
- 8.4.4.3. Product benchmarking
- 8.4.4.4. Strategic initiatives
- 8.4.5. OPEN Health
- 8.4.5.1. Company overview
- 8.4.5.2. Financial performance
- 8.4.5.3. Product benchmarking
- 8.4.5.4. Strategic initiatives
- 8.4.6. Real Chemistry
- 8.4.6.1. Company overview
- 8.4.6.2. Financial performance
- 8.4.6.3. Product benchmarking
- 8.4.6.4. Strategic initiatives
- 8.4.7. Health Inc.
- 8.4.7.1. Company overview
- 8.4.7.2. Financial performance
- 8.4.7.3. Product benchmarking
- 8.4.7.4. Strategic initiatives
- 8.4.8. VML.
- 8.4.8.1. Company overview
- 8.4.8.2. Financial performance
- 8.4.8.3. Product benchmarking
- 8.4.8.4. Strategic initiatives
- 8.4.9. Amiculum.
- 8.4.9.1. Company overview
- 8.4.9.2. Financial performance
- 8.4.9.3. Product benchmarking
- 8.4.9.4. Strategic initiatives
- 8.4.10. Cactus Life Sciences.
- 8.4.10.1. Company overview
- 8.4.10.2. Financial performance
- 8.4.10.3. Product benchmarking
- 8.4.10.4. Strategic initiatives
- 8.4.11. Avalere Health Group.
- 8.4.11.1. Company overview
- 8.4.11.2. Financial performance
- 8.4.11.3. Product benchmarking
- 8.4.11.4. Strategic initiatives
- 8.4.12. Oxford PharmaGenesis (Klick Inc.)
- 8.4.12.1. Company overview
- 8.4.12.2. Financial performance
- 8.4.12.3. Product benchmarking
- 8.4.12.4. Strategic initiatives
- 8.4.1. Inizio.
